CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 3 filers reported holding CTI BIOPHARMA CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $16,353,666 | -30.1% | 3,893,730 | 0.0% | 3.49% | -31.4% |
Q4 2022 | $23,401,317 | +2.0% | 3,893,730 | -1.3% | 5.09% | +6.2% |
Q3 2022 | $22,953,000 | -2.6% | 3,943,730 | -0.1% | 4.79% | -1.6% |
Q2 2022 | $23,574,000 | +30.8% | 3,948,730 | +2.3% | 4.87% | +52.2% |
Q1 2022 | $18,025,000 | +2807.3% | 3,859,707 | +1443.9% | 3.20% | +3197.9% |
Q4 2021 | $620,000 | – | 250,000 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|